ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
2,1,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
3,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3,4,Vasodilation procedure,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
4,1,Poland's syndrome,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
5,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
6,1,Deafness transitory,Hearing losses,Hearing disorders,Ear,N
7,1,Parotid gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
7,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
8,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
8,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
9,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
10,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
11,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
12,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
12,2,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
13,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
14,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
15,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
15,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
15,3,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
16,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
17,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
17,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
18,1,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
19,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
20,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
21,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
22,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
22,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
23,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
23,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
24,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
24,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
24,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
24,4,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
24,5,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
25,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
26,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
26,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
26,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
27,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
27,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
27,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
27,4,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
29,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
29,2,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
29,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
31,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
32,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
32,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
33,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
33,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
34,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
34,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
34,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
34,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
34,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
35,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
36,1,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
36,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
36,3,Vein disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
37,1,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
38,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
39,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
39,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
40,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
40,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
41,1,Torticollis,Muscle tone abnormalities,Muscle disorders,Musc,N
42,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
43,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
43,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
43,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
44,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
44,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
44,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
45,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
45,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
46,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
46,2,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
47,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
48,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
49,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
49,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
50,1,Headache,Headaches NEC,Headaches,Nerv,N
50,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
50,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
50,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
51,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
52,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
53,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
54,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
55,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
55,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
56,2,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
56,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
57,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
58,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
59,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
60,1,Headache,Headaches NEC,Headaches,Nerv,N
61,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
62,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
63,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
65,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
65,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
65,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
66,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
67,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
68,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
68,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
69,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
69,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
70,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
71,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
72,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
73,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
74,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
75,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
76,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
77,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
77,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
77,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
78,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
79,1,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
80,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,2,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
80,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
81,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
82,1,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
82,2,Retinal artery thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
83,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
84,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
84,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
84,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
84,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
85,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
86,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
87,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
87,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
87,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
88,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
89,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
90,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
91,1,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
92,1,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
93,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
94,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
95,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
95,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
96,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
97,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
98,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
99,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
99,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
99,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
100,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
100,2,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
101,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
102,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
103,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
105,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
105,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
106,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
107,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
108,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
109,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
110,1,Opisthotonus,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
111,1,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
112,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
113,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
114,1,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
115,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
115,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
115,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
115,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
116,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
116,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
116,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
116,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
116,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
117,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
118,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
119,1,Disturbance in sexual arousal,Sexual arousal disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
120,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
121,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,1,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
122,2,Oral mucosal roughening,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
122,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
123,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
124,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
124,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
124,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
125,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
126,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
127,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
127,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
128,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
128,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
129,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
129,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
130,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
130,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
131,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
131,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
131,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
132,1,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
132,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
133,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
134,1,Dysdiadochokinesis,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
134,2,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
135,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
136,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
137,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
138,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
138,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
139,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
139,2,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
140,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
140,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
140,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
141,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
142,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
143,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
143,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
144,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
144,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
144,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
144,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
144,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
145,1,Auricular swelling,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
145,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
145,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
145,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
145,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
145,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
145,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
146,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
147,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
147,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
148,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
149,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
149,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
149,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
149,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
150,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
151,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
152,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
152,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
152,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
152,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
152,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
153,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
153,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
153,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
153,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
153,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
154,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
154,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
155,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
155,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
156,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
157,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
157,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
157,3,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
158,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
158,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
159,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
159,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
159,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
160,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
160,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
161,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
162,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
163,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
163,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
163,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
163,4,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
163,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
163,6,Vasoconstriction,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
164,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
165,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
166,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
167,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
168,1,Tracheal stenosis,Tracheal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
169,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
169,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
169,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
169,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
170,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
171,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
172,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
173,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
173,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
174,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
174,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
175,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
176,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
176,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
177,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
177,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
178,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
178,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
179,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
180,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
181,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
181,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
181,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
181,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
182,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
182,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
182,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
183,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
183,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
184,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
184,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
184,3,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
184,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
185,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
186,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
187,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
187,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
187,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
188,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
188,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
188,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
189,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
190,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
191,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
192,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
193,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
194,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
195,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
195,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
196,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
197,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
197,2,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
197,3,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
198,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
199,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
199,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
199,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
200,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
200,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
200,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
200,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
202,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
202,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
202,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
203,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
203,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
203,3,Headache,Headaches NEC,Headaches,Nerv,N
203,4,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
204,1,Ventricular arrhythmia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
205,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
205,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
205,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
205,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
205,5,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
206,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
207,1,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
207,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
207,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
208,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
208,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
208,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
208,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
208,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
209,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
210,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
210,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
210,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
211,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
212,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
212,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
213,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
213,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
214,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
215,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
216,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
216,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
217,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
218,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
219,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
220,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
221,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
222,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
222,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
223,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
224,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
224,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
224,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
224,4,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
225,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
225,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
226,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
226,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
227,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
228,1,Deafness transitory,Hearing losses,Hearing disorders,Ear,N
229,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
230,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
230,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
230,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
230,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
230,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
231,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
232,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
232,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
233,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
233,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
233,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
234,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
234,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
235,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
236,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
236,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
237,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
237,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
238,1,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
238,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
238,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
239,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
239,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
239,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
239,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
239,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
240,1,Headache,Headaches NEC,Headaches,Nerv,N
240,2,Procedural nausea,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
241,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
241,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
242,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
242,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
243,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
244,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
244,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
244,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
244,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
244,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
244,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
244,7,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
244,8,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
244,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
245,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
246,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
246,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
247,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
248,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
249,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
249,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
250,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
251,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
252,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
252,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
252,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
253,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
253,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
254,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
255,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
255,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
256,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
256,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
256,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
257,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
257,2,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
258,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
259,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
259,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
259,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
260,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
261,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
261,2,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
261,3,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
262,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
262,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
262,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
263,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
264,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
264,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
265,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
265,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
266,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
267,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
268,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
268,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
268,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
269,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
270,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
270,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
271,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
271,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
271,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
272,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
273,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
273,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
274,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
274,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
275,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
275,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
275,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
275,4,Cyanosis central,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
275,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
275,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
275,7,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
275,8,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
275,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
275,10,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
276,1,Cyanosis central,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
276,2,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
276,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
276,4,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
277,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
277,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
277,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
277,4,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
277,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
277,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
277,7,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
277,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
277,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
277,10,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
278,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
278,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
278,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
278,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
278,5,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
278,6,Vasodilation procedure,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
279,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
279,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
280,1,Hyperthermia malignant,Body temperature altered,Body temperature conditions,Genrl,N
281,1,Breath holding,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
281,2,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
281,3,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
281,4,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
281,5,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
281,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
282,1,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
282,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
282,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
283,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
283,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
283,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
283,4,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
283,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
283,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
284,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
285,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
285,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
285,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
285,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
285,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
285,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
285,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
285,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
286,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
287,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
288,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
288,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
288,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
288,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
289,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
290,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
291,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
291,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
291,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
292,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
292,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
293,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
293,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
294,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
294,2,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
295,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
295,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
295,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
296,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
296,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
297,1,Atrioventricular dissociation,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
297,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
297,3,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
297,4,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
297,5,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
297,6,Headache,Headaches NEC,Headaches,Nerv,N
297,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
297,8,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
297,9,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
298,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
298,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
298,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
298,4,Headache,Headaches NEC,Headaches,Nerv,N
298,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
298,6,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
298,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
299,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
299,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
299,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
299,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
300,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
300,2,Electrocardiogram ST segment depression,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
300,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
300,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
300,5,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
301,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
301,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
301,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
301,4,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
302,1,Meningitis chemical,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
303,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
304,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
304,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
305,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
306,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
306,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
306,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
306,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
306,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
306,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
306,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
307,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
308,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
309,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
309,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
309,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
309,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
310,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
310,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
311,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
312,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
312,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
312,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
313,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
313,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
314,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
314,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
314,3,Sinus arrest,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
314,4,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
315,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
316,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
316,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
316,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
316,4,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
316,5,Intestinal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
316,6,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
316,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
317,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
318,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
318,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
319,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
319,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
320,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
320,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
321,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
321,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
322,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
322,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
322,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
323,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
323,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
323,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
323,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
324,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
325,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
326,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
327,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
328,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
329,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
330,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
330,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
331,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
331,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
331,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
331,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
332,1,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
333,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
333,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
333,3,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
334,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
335,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
335,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
335,3,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
336,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
336,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
337,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
338,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
339,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
340,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
341,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
341,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
342,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
342,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
343,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
343,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
343,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
343,4,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
343,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
343,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
343,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
344,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
344,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
344,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
345,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
345,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
345,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
345,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
346,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
346,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
347,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
347,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
347,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
348,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
349,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
349,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
350,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
350,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
350,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
350,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
350,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
351,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
352,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
353,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
353,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
354,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
354,2,Conversion disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
355,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
356,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
357,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
357,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
358,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
359,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
359,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
360,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
361,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
361,2,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
361,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
361,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
361,5,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
362,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
363,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
363,2,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
364,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
364,2,Migraine with aura,Migraine headaches,Headaches,Nerv,N
365,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
365,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
365,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
365,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
365,5,Migraine with aura,Migraine headaches,Headaches,Nerv,N
365,6,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
366,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
367,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
367,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
367,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
367,4,Migraine,Migraine headaches,Headaches,Nerv,N
367,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
367,6,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
367,7,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
367,8,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
368,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
369,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
370,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
371,1,Headache,Headaches NEC,Headaches,Nerv,N
371,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
371,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
372,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
373,1,Acarodermatitis,Ectoparasitic infestations,Ectoparasitic disorders,Infec,N
373,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
373,3,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
374,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
374,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
375,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
375,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
376,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
377,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
377,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
377,3,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
377,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
377,5,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
377,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
377,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
377,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
377,9,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
378,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
378,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
378,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
379,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
379,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
380,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
381,1,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
381,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
381,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
381,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
381,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
381,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
382,1,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
382,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
383,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
383,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
383,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
383,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
384,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
384,2,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
384,3,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
385,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
385,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
386,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
386,2,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
386,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
387,1,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
388,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
388,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
389,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
390,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
391,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
392,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
393,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
393,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
393,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
393,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
394,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
395,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
396,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
396,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
396,3,Headache,Headaches NEC,Headaches,Nerv,N
396,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
397,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
397,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
397,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
397,4,Electrocardiogram ST segment depression,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
397,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
397,6,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
397,7,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
398,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
398,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
398,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
398,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
398,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
399,1,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
399,2,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
400,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
400,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
401,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
401,2,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
402,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
402,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
403,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
403,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
404,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
404,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
404,3,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
404,4,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
405,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
405,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
405,3,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
406,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
407,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
407,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
408,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
408,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
408,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
408,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
409,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
409,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
409,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
410,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
410,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
410,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
410,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
411,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
411,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
411,3,Headache,Headaches NEC,Headaches,Nerv,N
411,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
411,5,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
412,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
412,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
412,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
412,4,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
413,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
414,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
415,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
416,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
416,2,Dysphoria,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
416,3,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
416,4,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
417,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
418,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
419,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
419,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
420,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
421,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
422,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
423,1,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
424,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
425,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
426,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
427,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
427,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
427,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
427,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
427,5,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
428,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
429,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
429,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
430,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
430,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
431,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
432,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
432,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
433,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
433,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
434,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
434,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
435,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
435,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
436,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
436,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
437,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
438,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
438,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
439,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
440,1,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
440,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
441,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
441,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
442,1,Gingival atrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
443,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
443,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
444,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
444,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
444,3,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
444,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
444,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
444,6,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
444,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
444,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
444,9,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
444,10,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
445,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
445,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
445,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
445,4,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
445,5,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
445,6,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
445,7,Vasodilation procedure,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
446,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
446,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
447,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
447,2,Anal injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
447,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
447,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
447,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
447,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
447,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
447,8,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
447,9,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
447,10,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
447,11,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
447,12,Morbid thoughts,Thinking disturbances,Disturbances in thinking and perception,Psych,N
447,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
447,14,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
447,15,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
447,16,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
447,17,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
447,18,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
448,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
448,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
448,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
449,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
449,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
450,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
450,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
451,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
451,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
451,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
451,4,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
452,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
453,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
453,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
453,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
453,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
454,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
454,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
454,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
455,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
456,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
456,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
457,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
457,2,Facial spasm,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
458,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
459,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
460,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
460,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
460,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
460,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
460,5,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
460,6,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
460,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
460,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
460,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
461,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
462,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
462,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
462,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
462,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
462,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
462,6,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
462,7,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
462,8,Therapeutic response increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
463,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
463,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
464,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
465,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
466,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
467,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
468,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
469,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
469,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
470,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
470,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
470,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
471,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
471,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
471,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
472,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
473,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
473,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
473,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
473,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
474,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
475,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
475,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
476,1,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
477,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
477,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
478,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
478,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
479,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
479,2,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
479,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
480,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
481,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
482,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
483,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
483,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
483,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
484,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
485,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
486,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
486,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
486,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
487,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
487,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
487,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
487,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
488,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
488,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
489,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
490,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
491,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
491,2,Endotracheal intubation complication,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
491,3,Hypoventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
491,4,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
492,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
493,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
493,2,Headache,Headaches NEC,Headaches,Nerv,N
494,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
494,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
494,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
495,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
496,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
496,2,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
496,3,Blood urea decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
496,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
496,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
497,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
497,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
497,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
497,4,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
497,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
497,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
498,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
498,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
498,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
498,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
499,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
500,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
500,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
500,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
500,4,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
500,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
501,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
502,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
502,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
503,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
503,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
503,3,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
503,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
504,1,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
504,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
504,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
505,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
505,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
506,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
506,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
506,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
506,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
506,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
507,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
507,2,Headache,Headaches NEC,Headaches,Nerv,N
507,3,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
507,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
508,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
508,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
508,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
508,4,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
509,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
509,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
509,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
509,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
510,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
511,1,Product label confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
512,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
512,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
512,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
512,4,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
512,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
512,6,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
512,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
513,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
513,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
514,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
514,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
514,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
515,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
515,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
515,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
516,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
516,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
516,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
517,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
517,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
518,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
518,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
518,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
519,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
519,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
520,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
520,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
520,3,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
521,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
522,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
523,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
524,1,Opiates positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
525,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
525,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
525,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
526,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
526,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
527,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
527,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
527,3,Device failure,Device issues NEC,Device issues,Prod,N
527,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
527,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
527,6,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
527,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
527,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
527,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
528,1,Device failure,Device issues NEC,Device issues,Prod,N
529,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
530,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
530,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
530,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
530,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
531,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
531,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
532,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
532,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
533,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
533,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
534,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
535,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
536,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
537,1,Device ineffective,Device issues NEC,Device issues,Prod,N
538,1,Device failure,Device issues NEC,Device issues,Prod,N
538,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
539,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
539,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
540,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
540,2,Drug abuser,Drug and chemical abuse,Lifestyle issues,SocCi,N
541,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
542,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
543,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
543,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
544,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
544,2,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
544,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
545,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
545,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
546,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
546,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
546,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
547,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
548,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
549,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
549,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
549,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
550,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
550,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
550,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
550,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
550,5,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
550,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
551,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
552,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
552,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
553,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
553,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
554,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
554,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
554,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
554,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
554,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
554,6,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
554,7,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
555,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
556,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
556,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
557,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
557,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
558,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
558,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
558,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
559,1,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
560,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
560,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
561,1,Device failure,Device issues NEC,Device issues,Prod,N
562,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
562,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
562,3,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
562,4,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
563,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
564,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
564,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
564,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
564,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
565,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
565,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
566,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
567,1,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
568,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,Y
569,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
569,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
569,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
570,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
570,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
571,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
571,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
571,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
572,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
573,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
573,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
573,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
573,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
573,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
573,6,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
573,7,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
573,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
573,9,Headache,Headaches NEC,Headaches,Nerv,N
573,10,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
573,11,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
573,12,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
573,13,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
573,14,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
573,15,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
573,16,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
573,17,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
573,18,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
574,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
575,1,Device ineffective,Device issues NEC,Device issues,Prod,N
575,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
576,1,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
576,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
576,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
577,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
577,2,Sickle cell anaemia with crisis,Sickle cell trait and disorders,Haemoglobinopathies,Blood,N
578,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
578,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
579,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
579,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
580,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
581,1,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
581,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
581,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
581,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
582,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
582,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
583,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
584,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
585,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
585,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
585,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
585,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
586,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
586,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
586,3,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
586,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
586,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
587,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
587,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
588,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
588,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
589,1,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
589,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
590,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
591,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
591,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
591,3,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
591,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
591,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
591,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
591,7,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
592,1,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
593,1,Physical assault,Criminal activity,Legal issues,SocCi,N
594,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
594,2,Physical assault,Criminal activity,Legal issues,SocCi,N
595,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
596,1,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
597,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
598,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
599,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
599,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
599,3,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
600,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
601,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
602,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
603,1,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
603,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
604,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
604,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
604,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
604,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
604,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
604,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
604,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
605,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
605,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
605,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
606,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
607,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
607,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
608,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
608,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
608,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
609,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
609,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
609,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
610,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
610,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
610,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
610,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
610,5,Sphincter of Oddi dysfunction,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
611,1,Bundle branch block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
611,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
611,3,Pathological fracture,Fractures NEC,Fractures,Musc,N
612,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
612,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
612,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
612,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
613,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
613,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
614,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
615,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
616,1,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
617,1,Injection site joint pain,Injection site reactions,Administration site reactions,Genrl,N
617,2,Injection site movement impairment,Injection site reactions,Administration site reactions,Genrl,N
617,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
618,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
618,2,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
619,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
619,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
620,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
621,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
621,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
621,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
622,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
622,2,Analgesic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
622,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
622,4,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
622,5,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
622,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
622,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
623,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
623,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
623,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
623,4,Oesophageal haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
624,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
624,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
625,1,Device leakage,Device issues NEC,Device issues,Prod,N
625,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
625,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
625,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
625,5,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
626,1,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
626,2,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
627,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,Y
628,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
629,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
630,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
630,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
631,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
631,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
631,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
632,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
632,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
632,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
632,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
632,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
633,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
633,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
633,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
633,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
633,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
633,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
633,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
634,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
634,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
634,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
634,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
634,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
634,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
635,1,Secondary hypogonadism,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
636,1,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
636,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
637,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
637,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
638,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
638,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
638,3,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
639,1,Gingival erosion,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
639,2,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
639,3,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
640,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
641,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
642,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
643,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
643,2,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
643,3,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
644,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
644,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
644,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
644,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
644,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
645,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
646,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
647,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
647,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
648,1,Therapeutic agent urine positive,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
649,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
650,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
651,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
651,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
651,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
652,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
652,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
652,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
652,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
653,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
653,2,Headache,Headaches NEC,Headaches,Nerv,N
654,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
654,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
655,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
655,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
655,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
655,4,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
655,5,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
655,6,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
655,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
656,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
656,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
657,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
658,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
658,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
658,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
658,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
658,5,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
659,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
660,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
660,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
660,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
660,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
661,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
662,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
662,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
662,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
663,1,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
663,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
663,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
663,4,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
663,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
663,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
663,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
663,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
663,9,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
664,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
664,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
664,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
664,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
665,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
665,2,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
666,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
666,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
667,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
667,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
668,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
669,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
669,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
669,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
669,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
670,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
670,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
670,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
670,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
670,5,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
670,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
670,7,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
670,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
670,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
670,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
671,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
672,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
673,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
674,1,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
675,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
675,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
676,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
676,2,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
676,3,Hemiplegic migraine,Migraine headaches,Headaches,Nerv,N
676,4,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
677,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
677,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
677,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
678,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
678,2,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
679,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
680,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
680,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
681,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
681,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
681,3,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
681,4,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
682,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
682,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
682,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
682,4,Self-destructive behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
683,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
683,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
683,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
683,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
683,5,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
683,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
683,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
683,8,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
684,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
684,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
684,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
685,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
685,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
685,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
685,4,Tachyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
686,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
686,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
686,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
686,4,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
686,5,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
686,6,Uterine contractions during pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
687,1,Asthmatic crisis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
687,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
687,3,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
687,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
687,5,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
687,6,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
687,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
688,1,Asthmatic crisis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
688,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
688,3,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
688,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
688,5,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
688,6,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
688,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
689,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
690,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
690,2,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
690,3,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
690,4,Dissociation,Dissociative states,Dissociative disorders,Psych,N
690,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
690,6,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
690,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
690,8,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
690,9,Indifference,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
690,10,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
691,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
691,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
692,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
692,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
692,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
693,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
693,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
694,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
694,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
694,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
695,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
696,1,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
696,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
697,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
697,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
698,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
699,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
699,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
700,1,Headache,Headaches NEC,Headaches,Nerv,N
700,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
700,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
700,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
701,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
702,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
703,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
703,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
704,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
704,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
704,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
705,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
705,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
706,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
706,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
707,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
708,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
709,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
709,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
710,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
711,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
711,2,Headache,Headaches NEC,Headaches,Nerv,N
711,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
711,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
712,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
712,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
712,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
713,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
714,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
715,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
716,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
717,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
718,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
719,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
720,1,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
721,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
722,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
723,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
724,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
724,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
724,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
725,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
725,2,Lasegue's test negative,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
725,3,Nerve stimulation test abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
726,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
726,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
726,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
727,1,Foetal heart rate decreased,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
728,1,Craniofacial fracture,"Skull fractures, facial bone fractures and dislocations",Bone and joint injuries,Inj&P,N
728,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
728,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
728,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
729,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
729,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
729,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
730,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
730,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
730,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
730,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
731,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
731,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
732,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
732,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
732,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
733,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
733,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
733,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
733,4,Headache,Headaches NEC,Headaches,Nerv,N
733,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
733,6,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
733,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
734,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
735,1,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
735,2,Hypoglossal nerve disorder,Hypoglossal nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
735,3,Trigeminal nerve disorder,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
736,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
737,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
737,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
738,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
738,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
739,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
740,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
740,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
740,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
740,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
741,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
742,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
742,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
742,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
742,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
743,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
743,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
743,3,Coma,Coma states,Neurological disorders NEC,Nerv,N
743,4,Food aversion,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
743,5,Hypoventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
743,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
743,7,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
743,8,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
743,9,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
744,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
744,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
745,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
746,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
747,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
747,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
748,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
748,2,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
748,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
748,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
748,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
748,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
748,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
748,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
748,9,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
748,10,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
748,11,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
748,12,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
748,13,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
748,14,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
749,1,Device adhesion issue,Device issues NEC,Device issues,Prod,N
749,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
750,1,Gingival discomfort,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
750,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
751,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
751,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
751,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
752,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
753,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
753,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
753,3,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
754,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
755,1,Inappropriate affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
755,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
755,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
756,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
756,2,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
757,1,Device adhesion issue,Device issues NEC,Device issues,Prod,N
757,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
758,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
758,2,Dizziness exertional,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
758,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
759,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
759,2,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
759,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
760,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
760,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
760,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
760,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
760,5,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
761,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
761,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
761,3,Oral mucosal erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
761,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
762,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
762,2,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
762,3,Drug clearance decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
762,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
762,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
763,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
763,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
764,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
764,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
765,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
766,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
766,2,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
766,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
766,4,Headache,Headaches NEC,Headaches,Nerv,N
766,5,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
766,6,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
766,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
766,8,Migraine with aura,Migraine headaches,Headaches,Nerv,N
766,9,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
767,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
767,2,Acute chest syndrome,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,Y
767,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
767,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
767,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
767,6,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
767,7,Sickle cell anaemia with crisis,Sickle cell trait and disorders,Haemoglobinopathies,Blood,N
768,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
768,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
769,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
769,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
770,1,Device adhesion issue,Device issues NEC,Device issues,Prod,N
770,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
770,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
771,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
771,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
771,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
771,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
771,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
771,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
772,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
773,1,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
773,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
774,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
774,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
774,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
775,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
775,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
776,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
776,2,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
777,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
777,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
778,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
778,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
779,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
780,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
780,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
781,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
781,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
782,1,Gingival ulceration,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
783,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
783,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
783,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
783,4,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
784,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
784,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
784,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
784,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
784,5,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
785,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
785,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
785,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
786,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
786,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
787,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
788,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
789,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
789,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
790,1,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
791,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
791,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
791,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
791,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
792,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
792,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
793,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
793,2,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
793,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
793,4,Lasegue's test negative,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
793,5,Nerve stimulation test abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
794,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
795,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
795,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
795,3,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
795,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
795,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
796,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
796,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
797,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
798,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
798,2,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
798,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
798,4,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
799,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
799,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
799,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
799,4,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
799,5,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
799,6,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
800,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
800,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
801,1,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
801,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
802,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
802,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
802,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
803,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
804,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
804,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
805,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
805,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
805,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
805,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
805,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
805,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
805,7,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
805,8,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
806,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
806,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
807,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
808,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
808,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
809,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
810,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
810,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
810,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
810,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
810,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
810,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
810,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
810,8,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
810,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
810,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
810,11,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
811,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
811,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
812,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
812,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
812,3,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
813,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
813,2,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
813,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
813,4,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
813,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
814,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
814,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
815,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
816,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
816,2,Device adhesion issue,Device issues NEC,Device issues,Prod,N
816,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
817,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
817,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
818,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
818,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
818,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
819,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
820,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
820,2,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
820,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
820,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
820,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
820,6,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
820,7,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
821,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
821,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
822,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
822,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
822,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
823,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
823,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
823,3,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
823,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
823,5,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
824,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
824,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
824,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
825,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
825,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
825,3,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
826,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
826,2,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
826,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
827,1,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
827,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
827,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
828,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
828,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
828,3,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
828,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
828,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
829,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
829,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
829,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
829,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
829,5,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
829,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
829,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
829,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
829,9,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
830,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
830,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
830,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
830,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
830,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
831,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
831,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
831,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
831,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
831,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
832,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
833,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
833,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
833,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
833,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
833,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
833,6,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
833,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
834,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
834,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
834,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
834,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
835,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
835,2,Eyelid function disorder,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
835,3,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
835,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
835,5,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
835,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
836,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
836,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
836,3,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
836,4,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
836,5,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
836,6,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
836,7,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
836,8,Congestive hepatopathy,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
836,9,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
836,10,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
836,11,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
836,12,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
836,13,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
836,14,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
836,15,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
836,16,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
836,17,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
836,18,Hepatic ischaemia,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
836,19,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
836,20,Hepatorenal syndrome,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
836,21,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
836,22,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
836,23,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
836,24,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
836,25,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
836,26,Muscle relaxant therapy,Muscle therapeutic procedures,Soft tissue therapeutic procedures,Surg,N
836,27,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
836,28,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
836,29,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
836,30,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
836,31,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
837,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
837,2,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
838,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
838,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
839,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
840,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
840,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
840,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
841,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
842,1,Device adhesion issue,Device issues NEC,Device issues,Prod,N
842,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
842,3,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
843,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
843,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
844,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
844,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
844,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
845,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
845,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
845,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
845,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
846,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
846,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
847,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
848,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
848,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
849,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
849,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
849,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
850,1,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
850,2,Intestinal operation,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
851,1,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
852,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
853,1,Apgar score low,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
853,2,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
854,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
854,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
854,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
854,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
854,5,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
854,6,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
854,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
855,1,Headache,Headaches NEC,Headaches,Nerv,N
855,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
855,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
856,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
856,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
857,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
857,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
857,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
857,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
857,5,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
857,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
857,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
858,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
859,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
860,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
860,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
860,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
860,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
861,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
862,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
863,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
863,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
863,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
864,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
864,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
865,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
866,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
867,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
867,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
867,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
867,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
868,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
869,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
869,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
869,3,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
869,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
870,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
870,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
870,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
870,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
871,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
871,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
871,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
871,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
872,1,Device adhesion issue,Device issues NEC,Device issues,Prod,N
872,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
872,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
873,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
873,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
874,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
874,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
874,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
874,4,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
874,5,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
874,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
874,7,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
874,8,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
874,9,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
874,10,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
874,11,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
874,12,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
874,13,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
874,14,Headache,Headaches NEC,Headaches,Nerv,N
874,15,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
874,16,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
874,17,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
874,18,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
874,19,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
874,20,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
874,21,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
874,22,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
874,23,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
874,24,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
874,25,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
874,26,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
874,27,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
874,28,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
874,29,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
874,30,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
874,31,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
875,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
875,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
875,3,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
875,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
875,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
876,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
876,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
876,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
876,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
876,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
876,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
877,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
877,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
878,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
878,2,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
878,3,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
878,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
878,5,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
878,6,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
878,7,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
878,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
878,9,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
878,10,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
878,11,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
879,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
880,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
881,1,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
882,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
883,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
883,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
884,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
884,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
884,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
885,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
886,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
886,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
886,3,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
886,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
886,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
887,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
888,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
889,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
890,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
890,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
891,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
891,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
891,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
891,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
891,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
892,1,Device adhesion issue,Device issues NEC,Device issues,Prod,N
892,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
893,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
894,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
894,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
894,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
894,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
895,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
896,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
897,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
898,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
899,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
899,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
900,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
900,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
900,3,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
901,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
902,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
903,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
903,2,Hypoventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
903,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
903,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
904,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
905,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
906,1,Device adhesion issue,Device issues NEC,Device issues,Prod,N
906,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
906,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
907,1,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
908,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
908,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
909,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
909,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
909,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
910,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
910,2,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
910,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
910,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
911,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
911,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
912,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
912,2,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
912,3,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
912,4,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
912,5,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
912,6,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
912,7,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
912,8,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
912,9,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
912,10,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
912,11,Delirium,Deliria,Deliria (incl confusion),Psych,N
912,12,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
912,13,Delusion of replacement,Delusional symptoms,Disturbances in thinking and perception,Psych,N
912,14,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
912,15,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
912,16,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
912,17,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
912,18,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
912,19,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
912,20,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
912,21,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
912,22,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
912,23,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
912,24,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
912,25,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
912,26,Hypervigilance,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
912,27,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
912,28,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
912,29,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
912,30,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
912,31,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
912,32,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
912,33,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
912,34,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
912,35,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
912,36,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
912,37,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
912,38,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
912,39,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
912,40,Self esteem decreased,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
912,41,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,Y
912,42,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
912,43,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
912,44,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
912,45,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
912,46,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
912,47,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
913,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
913,2,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
914,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
914,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
914,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
914,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
914,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
914,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
915,1,Device adhesion issue,Device issues NEC,Device issues,Prod,N
915,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
915,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
915,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
916,1,Foetal heart rate deceleration abnormality,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
917,1,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
918,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
918,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
918,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
919,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
919,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
919,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
920,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
920,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
920,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
921,1,Administration related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
921,2,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
921,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
922,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
922,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
923,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
924,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
925,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
926,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
926,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
927,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
928,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
928,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
929,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
929,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
929,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
929,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
930,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
930,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
930,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
931,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
932,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
932,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
933,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
933,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
934,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
934,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
935,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
935,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
935,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
935,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
935,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
936,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
936,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
936,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
937,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
937,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
937,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
938,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
938,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
939,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
939,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
939,3,Headache,Headaches NEC,Headaches,Nerv,N
939,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
939,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
939,6,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
939,7,Phaeochromocytoma,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
939,8,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
939,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
939,10,Ventricular failure,Heart failures NEC,Heart failures,Card,N
940,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
940,2,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
940,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
941,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
941,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
942,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
942,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
942,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
943,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
944,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
944,2,Bradypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
944,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
944,4,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
944,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
944,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
945,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
945,2,Bradypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
945,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
945,4,Drug diversion,Criminal activity,Legal issues,SocCi,N
945,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
945,6,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
945,7,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
945,8,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
945,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
946,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
946,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
946,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
946,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
946,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
946,6,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
947,1,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
947,2,Therapeutic product effect prolonged,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
948,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
948,2,Bradypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
948,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
948,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
948,5,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
948,6,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
948,7,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
948,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
949,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
949,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
949,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
949,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
949,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
949,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
950,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
950,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
950,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
950,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
950,5,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
950,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
951,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
951,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
951,3,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
951,4,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
952,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
953,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
953,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
953,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
954,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
954,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
954,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
954,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
954,5,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
954,6,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
954,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
954,8,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
955,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
955,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
955,3,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
955,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
955,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
955,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
955,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
955,8,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
955,9,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
955,10,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
955,11,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
955,12,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
956,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
956,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
957,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
958,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
959,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
959,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
960,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
961,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
961,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
961,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
961,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
961,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
961,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
961,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
961,8,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
961,9,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
961,10,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
961,11,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
961,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
962,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
963,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
963,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
963,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
963,4,Coma,Coma states,Neurological disorders NEC,Nerv,N
963,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
963,6,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
963,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
963,8,Hyperthermia,Body temperature altered,Body temperature conditions,Genrl,N
963,9,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
963,10,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
963,11,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
963,12,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
963,13,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
964,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
964,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
965,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
965,2,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
965,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
966,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
966,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
966,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
966,4,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
966,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
966,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
967,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
968,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
968,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
968,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
968,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
968,5,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
968,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
969,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
969,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
970,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
971,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
972,1,Neonatal disorder,Newborn complications NEC,Neonatal and perinatal conditions,Preg,N
973,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
973,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
973,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
973,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
974,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
975,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
975,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
976,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
976,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
976,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
976,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
976,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
977,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
977,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
977,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
977,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
977,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
977,6,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
978,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
978,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
979,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
979,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
980,1,Sciatic nerve injury,Peripheral nerve injuries,Injuries NEC,Inj&P,N
981,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
981,2,Diabetic neuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
981,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
981,4,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
981,5,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
981,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
982,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
983,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
983,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
983,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
983,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
983,5,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
984,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
984,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
985,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
985,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
985,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
985,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
986,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
986,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
986,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
986,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
987,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
987,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
988,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
989,1,Allodynia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
989,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
990,1,Complex regional pain syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
991,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
991,2,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
991,3,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
991,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
991,5,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
991,6,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
991,7,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
992,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
992,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
992,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
992,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
992,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
993,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
994,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
994,2,Vein discolouration,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
995,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
996,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
997,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
998,1,Application site scar,Application site reactions,Administration site reactions,Genrl,N
999,1,Complex regional pain syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
999,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
999,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1000,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1000,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1000,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1001,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1001,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1001,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1001,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1002,1,Application site eczema,Application site reactions,Administration site reactions,Genrl,N
1002,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1002,3,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1002,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1002,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1003,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1003,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1003,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1003,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1003,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1004,1,Analgesic drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1004,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1005,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1006,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1006,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1006,3,Buttock injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1006,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1006,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1006,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1006,7,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1006,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1006,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1006,10,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1006,11,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1006,12,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1006,13,Indifference,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1006,14,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1006,15,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1006,16,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1006,17,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1006,18,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1006,19,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1006,20,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1007,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1008,1,Device adhesion issue,Device issues NEC,Device issues,Prod,N
1008,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1009,1,Blood testosterone decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
1009,2,Disturbance in sexual arousal,Sexual arousal disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1009,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1009,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1009,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1009,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1009,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1010,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
1010,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1010,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1010,4,Teeth brittle,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1010,5,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1011,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1012,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1013,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1014,1,Narcotic bowel syndrome,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
1015,1,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1015,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1015,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1016,1,Narcotic bowel syndrome,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
1017,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1018,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1018,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1018,3,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1018,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1018,5,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1019,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1019,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1019,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1019,4,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
1019,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1019,6,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1019,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1020,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1020,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1020,3,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
1020,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1020,5,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1020,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1020,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1020,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1020,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1020,10,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1020,11,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1021,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1021,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1021,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1021,4,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1021,5,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1021,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1021,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1021,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1021,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1021,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1021,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1021,12,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1021,13,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1022,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1022,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1022,3,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1022,4,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1022,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1022,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1022,7,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
1022,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1022,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1022,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1022,11,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1022,12,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1023,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1023,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1023,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1024,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1025,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1025,2,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1025,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1026,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1026,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1026,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1026,4,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1026,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1027,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1027,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1028,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1028,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1028,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1029,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,Y
1030,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1030,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1030,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1030,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1030,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1031,1,Application site scar,Application site reactions,Administration site reactions,Genrl,N
1031,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1032,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1032,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1033,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1033,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1034,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,Y
1034,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1034,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1035,1,Narcotic bowel syndrome,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
1036,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1036,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1036,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1037,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1037,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1037,3,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1038,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1038,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1039,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1039,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1039,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1039,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1040,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1040,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1041,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1042,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1042,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1043,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1043,2,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1043,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1044,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1044,2,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1044,3,High-pitched crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1044,4,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1044,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1044,6,Reflexes abnormal,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1044,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1045,1,Headache,Headaches NEC,Headaches,Nerv,N
1045,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1045,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1045,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1045,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1046,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1046,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1046,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1046,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1046,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1046,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1046,7,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1047,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1047,2,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1048,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1048,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1048,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1048,4,Cardiac output decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1049,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1049,2,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1050,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1050,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1050,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1050,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1050,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1051,1,Anhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1051,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1051,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1051,4,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1051,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1051,6,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1051,7,Prolonged pregnancy,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1052,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1053,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1053,2,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1054,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1055,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1055,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1055,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1055,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1055,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1055,6,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1056,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1056,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1056,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1056,4,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1056,5,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1056,6,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1056,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1057,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1057,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1057,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1058,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1059,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1059,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1059,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1060,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1060,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1061,1,Muscle rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1062,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1062,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1063,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
1063,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1064,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1064,2,Neonatal disorder,Newborn complications NEC,Neonatal and perinatal conditions,Preg,N
1065,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1065,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1066,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
1066,2,Drug diversion,Criminal activity,Legal issues,SocCi,N
1066,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1066,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1067,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1068,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1068,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1069,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1069,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1069,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1069,4,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1069,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1069,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1070,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1070,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1070,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1070,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1071,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1072,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1072,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1072,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1072,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1072,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1072,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1072,7,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1072,8,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1072,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1072,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1072,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1073,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
1073,2,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1074,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
1074,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1074,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1074,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1075,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1075,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1075,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1076,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1076,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1077,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1077,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1077,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1078,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1078,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1078,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1078,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1079,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1079,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1080,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1080,2,Drug diversion,Criminal activity,Legal issues,SocCi,N
1080,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1081,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1082,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1082,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1082,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1083,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1084,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1084,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1084,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1085,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1085,2,Contraindication to medical treatment,Social issues NEC,Lifestyle issues,SocCi,N
1085,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1086,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1086,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1086,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1086,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1087,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1087,2,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1087,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1087,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1087,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1088,1,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1088,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1089,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1089,2,Gallbladder operation,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
1090,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1090,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1091,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1091,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1091,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1092,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1092,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1092,3,Drug diversion,Criminal activity,Legal issues,SocCi,N
1092,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1092,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1093,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1094,1,Application site laceration,Application site reactions,Administration site reactions,Genrl,N
1094,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1094,3,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1094,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1095,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1095,2,Therapeutic reaction time decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1095,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1096,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1096,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1097,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1097,2,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1097,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1097,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1097,5,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1097,6,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1097,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1097,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1098,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1098,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1098,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1098,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1099,1,Dissociative amnesia,Dissociative states,Dissociative disorders,Psych,N
1100,1,Stroke volume decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1101,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1101,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1101,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1101,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1101,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1101,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1101,7,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1101,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1101,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1101,10,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1101,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1102,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1102,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1103,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1103,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1104,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1105,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1106,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1106,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1106,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1106,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1107,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1107,2,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1107,3,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1107,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1108,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1108,2,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1108,3,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1108,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1108,5,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1108,6,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1108,7,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1108,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1108,9,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1108,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1108,11,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1109,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1109,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1109,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1110,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1110,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1111,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1112,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1112,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1112,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1113,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1114,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1114,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1115,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1115,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1115,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1116,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1117,1,Essential hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1118,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1118,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1118,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1118,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1118,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1118,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1119,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
1119,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1119,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1119,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1120,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1121,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1122,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1123,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
1124,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1124,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1124,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1124,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1124,5,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1124,6,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1124,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1124,8,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1124,9,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
1124,10,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1125,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1126,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1126,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1127,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
1127,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1128,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1128,2,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1128,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1128,4,Decerebrate posture,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1128,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1129,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1129,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1129,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1130,1,Postoperative thrombosis,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1131,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1131,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1131,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1131,4,Nerve block,Anaesthesia and allied procedures,Therapeutic procedures and supportive care NEC,Surg,N
1131,5,Post lumbar puncture syndrome,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1132,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1132,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1133,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1133,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1134,1,Anaesthetic complication cardiac,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1134,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1134,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1134,4,Procedural headache,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1135,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1136,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1137,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1137,2,Headache,Headaches NEC,Headaches,Nerv,N
1137,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1137,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1137,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1137,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1138,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1138,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1138,3,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1138,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1138,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1138,6,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1138,7,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1138,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1138,9,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1138,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1139,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1139,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1139,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1139,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1139,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1139,6,Headache,Headaches NEC,Headaches,Nerv,N
1139,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1139,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1139,9,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1140,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1140,2,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
1140,3,Headache,Headaches NEC,Headaches,Nerv,N
1141,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
1142,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
1142,2,Leukoderma,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1142,3,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1142,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1142,5,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1143,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1144,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1145,1,Narcotic bowel syndrome,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
1146,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1147,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1147,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1147,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1148,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1149,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1149,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1150,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1151,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1151,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1151,3,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1152,1,Apgar score low,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1152,2,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1152,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1153,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1153,2,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1154,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1154,2,Enophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
1154,3,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1154,4,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1154,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1154,6,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1154,7,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1155,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1155,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1156,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1156,2,Foetal heart rate deceleration abnormality,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1156,3,Foetal heart rate decreased,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
1157,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1157,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1157,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1158,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1158,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1159,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1159,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1160,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1160,2,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1160,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1161,1,Dissociative amnesia,Dissociative states,Dissociative disorders,Psych,N
1162,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1163,1,Apgar score low,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1163,2,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1163,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1163,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1164,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1164,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1165,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1165,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1165,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1165,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
1166,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1166,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1167,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1167,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1167,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1167,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1167,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1167,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1168,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1169,1,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1169,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1169,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1170,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1171,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1171,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1171,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1171,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1171,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1172,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1172,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1172,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1172,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1172,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1172,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1172,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1172,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1173,1,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1173,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1174,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1174,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1175,1,Confusion postoperative,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1175,2,Mental status changes postoperative,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1175,3,Metabolic alkalosis,Metabolic alkaloses,Acid-base disorders,Metab,N
1175,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1176,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1177,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1177,2,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,Y
1178,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1178,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1178,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1179,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1179,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1180,1,Complex regional pain syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1180,2,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
1180,3,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1181,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1181,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1182,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1183,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1183,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1184,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1184,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1184,3,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
1184,4,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1185,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1186,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1186,2,Headache,Headaches NEC,Headaches,Nerv,N
1186,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1186,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1186,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1186,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1187,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1187,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1187,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1188,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1188,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1188,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1189,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1189,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1190,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1191,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1191,2,Drug diversion,Criminal activity,Legal issues,SocCi,N
1191,3,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1191,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1191,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1191,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1191,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1192,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1192,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1192,3,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1193,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1193,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1193,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1193,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1194,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1194,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1194,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1195,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1195,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1195,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1196,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1196,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1197,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1198,1,Neuromuscular block prolonged,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1199,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1200,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1200,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1201,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1202,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1202,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1202,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1202,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1202,5,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1202,6,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1202,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1202,8,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1203,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1204,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1204,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1204,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1204,4,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1204,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1205,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1205,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1205,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1206,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1206,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1207,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1208,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1209,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1210,1,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1210,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1210,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1210,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1210,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1210,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1210,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1211,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1212,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1213,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1214,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1214,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1214,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1214,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1214,5,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1214,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1214,7,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1214,8,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1214,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1215,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
1215,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1215,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1216,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1216,2,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1216,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1216,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1217,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1217,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1217,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1217,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1217,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1218,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1218,2,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1218,3,Snoring,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1218,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1219,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1220,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1220,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1220,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1220,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1220,5,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1220,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1221,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1222,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1222,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1223,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1224,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1224,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1224,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1224,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1224,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1225,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1225,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1225,3,Hyperthermia malignant,Body temperature altered,Body temperature conditions,Genrl,N
1225,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1225,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1226,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1226,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1227,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1227,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1227,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1227,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1227,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1227,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1227,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1228,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1229,1,Drug diversion,Criminal activity,Legal issues,SocCi,N
1229,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1229,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
1229,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1230,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1230,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1230,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1230,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1230,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1231,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1232,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1233,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
1233,2,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
1234,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1235,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1236,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1236,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1237,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1238,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1239,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1239,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1239,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1240,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1240,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1240,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1241,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1241,2,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1241,3,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1242,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1242,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
1242,3,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1242,4,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1242,5,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1242,6,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1242,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1243,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1243,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1243,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1244,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1245,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1245,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1246,1,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1247,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1247,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1247,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1247,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1247,5,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1248,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1248,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1249,1,Medication overuse headache,Headaches NEC,Headaches,Nerv,N
1250,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1250,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1250,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1250,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1251,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1251,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1251,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1251,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1251,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1252,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1252,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1252,3,Headache,Headaches NEC,Headaches,Nerv,N
1252,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1252,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1252,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1252,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1253,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1253,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1254,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1254,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1255,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1256,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1257,1,Torticollis,Muscle tone abnormalities,Muscle disorders,Musc,N
1258,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1259,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1260,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1261,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1261,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1262,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1262,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1262,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1263,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1263,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1264,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1265,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1266,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1267,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1267,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1267,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1267,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1268,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1269,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1269,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1270,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1270,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1270,3,Feelings of worthlessness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1270,4,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1270,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1270,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1270,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1271,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1272,1,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1272,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1272,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1273,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1274,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1275,1,Drug screen positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
1275,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1275,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1276,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1277,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1277,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,Y
1278,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1278,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1279,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1279,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1279,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1279,4,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1280,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1281,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1281,2,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
1281,3,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1282,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1283,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1284,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1284,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1285,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1285,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1285,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1285,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1285,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1285,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1285,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1285,8,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1285,9,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1286,1,Device failure,Device issues NEC,Device issues,Prod,N
1286,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1286,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1286,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1286,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1287,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1288,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1288,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1288,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1288,4,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1288,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1288,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1288,7,Migraine,Migraine headaches,Headaches,Nerv,N
1288,8,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1288,9,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1288,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1288,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1288,12,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1288,13,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1288,14,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1289,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1289,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1290,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1290,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1291,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1291,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1292,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1292,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1292,3,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1293,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1293,2,Sickle cell anaemia with crisis,Sickle cell trait and disorders,Haemoglobinopathies,Blood,N
1293,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1293,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1294,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1294,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1295,1,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
1295,2,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1295,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1295,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1296,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1296,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1297,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1297,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1297,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1298,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1298,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1298,3,Metabolic alkalosis,Metabolic alkaloses,Acid-base disorders,Metab,N
1298,4,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1298,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1298,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1299,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1299,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1299,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1299,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1299,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1300,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1301,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1301,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1301,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1302,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1302,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1303,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1303,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1303,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1304,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1304,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1304,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1305,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1305,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1306,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1306,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1307,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1307,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1307,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1307,4,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1307,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1307,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1307,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1307,8,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1308,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1308,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1308,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1308,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1309,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1309,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1309,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1309,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1309,5,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1310,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1310,2,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
1310,3,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1310,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1311,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1311,2,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1311,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1311,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1312,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1312,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1312,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1312,4,Madarosis,Alopecias,Skin appendage conditions,Skin,N
1312,5,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1312,6,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1312,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1312,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1312,9,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
1312,10,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1313,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1313,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1314,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
1314,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1314,3,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1314,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1315,1,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1316,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1317,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1318,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1319,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1319,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1319,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1319,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1319,5,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1319,6,Dissociative amnesia,Dissociative states,Dissociative disorders,Psych,N
1319,7,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1319,8,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1319,9,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1319,10,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1319,11,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1319,12,Headache,Headaches NEC,Headaches,Nerv,N
1319,13,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1319,14,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1319,15,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1319,16,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1319,17,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1319,18,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1319,19,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1319,20,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1319,21,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1319,22,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1319,23,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1319,24,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1319,25,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1319,26,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1319,27,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1319,28,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1319,29,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1319,30,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1320,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1320,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1321,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,Y
1321,2,Death,Death and sudden death,Fatal outcomes,Genrl,N
1322,1,Device issue,Device issues NEC,Device issues,Prod,N
1322,2,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1322,3,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1323,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1324,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1324,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1324,3,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1324,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1324,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1324,6,Headache,Headaches NEC,Headaches,Nerv,N
1324,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1324,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1325,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1325,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1325,3,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1325,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1325,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1326,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1326,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1326,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1326,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1326,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1326,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1327,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1328,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1328,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
1328,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1328,4,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1328,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1328,6,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1328,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1328,8,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1328,9,Pneumonitis chemical,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
1328,10,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1328,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1328,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1329,1,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1329,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1329,3,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1329,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1329,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1330,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1331,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1331,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1332,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1333,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1334,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1334,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1335,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1336,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1337,1,Behavioural addiction,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1337,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1338,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1339,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1340,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1341,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1342,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1342,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1342,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1342,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1342,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1342,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1343,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1344,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,Y
1344,2,Death,Death and sudden death,Fatal outcomes,Genrl,N
1345,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1345,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1345,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1346,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1347,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1347,2,Myoclonic epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1348,1,Arachnoiditis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
1348,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1348,3,Cauda equina syndrome,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
1348,4,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1349,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1349,2,Application site scab,Application site reactions,Administration site reactions,Genrl,N
1349,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1350,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1351,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1352,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1352,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1353,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1354,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1355,1,Procedural nausea,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1355,2,Procedural vomiting,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1356,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1357,1,Postoperative respiratory failure,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1358,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1359,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1359,2,Carcinoid crisis,Ectopic endocrine disorders,Neoplastic and ectopic endocrinopathies,Endo,N
1360,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1360,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1360,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1360,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1360,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1361,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1362,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1362,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1362,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1363,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1363,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1364,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1364,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1364,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1365,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1365,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1366,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1367,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
1368,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1368,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1368,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1369,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1370,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1370,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1370,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1371,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1371,2,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1371,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1371,4,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1372,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1373,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1373,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1373,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1373,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1374,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1374,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1374,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1374,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1374,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1374,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1375,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1375,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1375,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1375,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1375,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1375,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1375,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1375,8,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1375,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1375,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1375,11,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1375,12,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1375,13,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1375,14,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1375,15,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1375,16,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1375,17,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1375,18,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
1375,19,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1375,20,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1375,21,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1376,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1376,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1376,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1376,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1376,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1376,6,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1376,7,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1376,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1376,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1377,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1377,2,Drug diversion,Criminal activity,Legal issues,SocCi,N
1377,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1377,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1378,1,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1378,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1378,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1378,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1379,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1379,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1380,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1381,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1382,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1382,2,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1382,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1383,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
1383,2,Dermatitis infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1383,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1383,4,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1383,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1384,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1385,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1385,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1386,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1387,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1388,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1388,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1389,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1389,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1389,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1389,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1389,5,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1389,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1389,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1389,8,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1389,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1389,10,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1389,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1389,12,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1389,13,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1389,14,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1389,15,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1390,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1390,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1391,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1391,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1391,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1391,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1391,5,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1391,6,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1391,7,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1391,8,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1391,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1391,10,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1391,11,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1391,12,Headache,Headaches NEC,Headaches,Nerv,N
1391,13,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1391,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1391,15,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1391,16,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1391,17,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1391,18,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1391,19,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1391,20,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1391,21,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1391,22,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1391,23,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1392,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1392,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1392,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1392,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1392,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1392,6,Drug use disorder,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1392,7,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1392,8,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1392,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1392,10,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1392,11,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1392,12,Headache,Headaches NEC,Headaches,Nerv,N
1392,13,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1392,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1392,15,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1392,16,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1392,17,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1392,18,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1392,19,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1392,20,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1392,21,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1392,22,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1392,23,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
1392,24,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1392,25,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1393,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1394,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
1394,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1394,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1394,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1394,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1394,6,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1394,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1394,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1395,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1395,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1395,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1395,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1396,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1396,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1396,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1396,4,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1396,5,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1397,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1397,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1397,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1397,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1397,5,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1397,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1398,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1398,2,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1398,3,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1398,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1399,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1400,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1401,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1402,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1402,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1402,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1402,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1402,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1403,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1403,2,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1403,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1403,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1403,5,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1403,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1403,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1403,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1404,1,Diplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1404,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1405,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1405,2,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1405,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1405,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1405,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1405,6,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1405,7,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1405,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1406,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1406,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1406,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1406,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1406,5,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1407,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1407,2,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1407,3,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1408,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1408,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1408,3,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
1408,4,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1408,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1408,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1408,7,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1409,1,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
1409,2,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1409,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1410,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1410,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1410,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1410,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1410,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1410,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1411,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1411,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1411,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1411,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1411,5,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1411,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1411,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1411,8,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1411,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1411,10,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1411,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1412,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1412,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1413,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1413,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1413,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1413,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1414,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1414,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1414,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1414,4,Product deposit,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1414,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1415,1,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1415,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1415,3,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
1415,4,Uterine hypotonus,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
1416,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1416,2,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1416,3,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1417,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1418,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1419,1,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1420,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1420,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1420,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1421,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1422,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1422,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1422,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1422,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1422,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1423,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1423,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1424,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1424,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1424,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1425,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1425,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1426,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1427,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1427,2,Foetal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1428,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1428,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1429,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1430,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1430,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1430,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1430,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1430,5,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1431,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1431,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1432,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1432,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1432,3,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1433,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1433,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1434,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1434,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1434,3,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1435,1,Drug-device interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1435,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1436,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1437,1,Impaired gastric emptying,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1437,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1437,3,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
1438,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1438,2,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1438,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1438,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1438,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1438,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1438,7,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1438,8,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1438,9,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1438,10,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1438,11,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1438,12,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1438,13,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1438,14,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1438,15,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
1438,16,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1439,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1439,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1439,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1439,4,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1439,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1439,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1439,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1439,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1439,9,Sopor,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1439,10,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1439,11,Therapy naive,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1439,12,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1439,13,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1440,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
1441,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1441,2,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1441,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1442,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1442,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1443,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1443,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1444,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1444,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1445,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1445,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1445,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1445,4,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1445,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1445,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1445,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1445,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1445,9,Sopor,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1445,10,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1445,11,Therapy naive,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1445,12,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1445,13,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1446,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1446,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1446,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1446,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1446,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1446,6,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1446,7,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1446,8,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1446,9,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1446,10,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1446,11,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1446,12,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1446,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1446,14,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1446,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1447,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1447,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1448,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1448,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1449,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1449,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1449,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1449,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1449,5,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1450,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1451,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1452,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
1452,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1453,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1454,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
1454,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1454,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1454,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1454,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1454,6,Rubber sensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1454,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1455,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1455,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1455,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1456,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1457,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1457,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1457,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1457,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1457,5,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1458,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1458,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1458,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1459,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1459,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1460,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1461,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1461,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1461,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1461,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1462,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1462,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1462,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1462,4,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1463,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1464,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1464,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1464,3,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1464,4,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1464,5,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1464,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1464,7,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1464,8,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1465,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
1465,2,Manufacturing production issue,Manufacturing production issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1466,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1466,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1466,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1466,4,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1466,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1467,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1468,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1468,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1468,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1468,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1468,5,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1468,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1468,7,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1468,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1468,9,Tonic clonic movements,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1468,10,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1469,1,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1469,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1470,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1471,1,Postoperative hypertension,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1472,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1473,1,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1474,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1474,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1474,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1474,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1474,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1474,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1474,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1474,8,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1474,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1475,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1475,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1475,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1475,4,Procedural hypotension,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1475,5,Tryptase increased,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
1476,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1476,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1477,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1478,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1478,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1478,3,Headache,Headaches NEC,Headaches,Nerv,N
1478,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1478,5,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1478,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1478,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1478,8,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1478,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1478,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1478,11,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1478,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1478,13,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1479,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1479,2,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1479,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1479,4,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1479,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1480,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1481,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1481,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1481,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1481,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1481,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1481,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1481,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1481,8,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1481,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1482,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1483,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1483,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1484,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1484,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1484,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1484,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1485,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
1485,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1486,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
1486,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1487,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
1487,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1488,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1488,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1489,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1489,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1490,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
1490,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1491,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1491,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1491,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1491,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1492,1,Procedural nausea,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1492,2,Procedural vomiting,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1492,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1493,1,Hypoventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1493,2,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1493,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1494,1,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1494,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1494,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1494,4,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1494,5,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1494,6,Lagophthalmos,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
1494,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1494,8,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1495,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1496,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1496,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1496,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1496,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1496,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1496,6,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1496,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1497,1,Cross sensitivity reaction,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1497,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1498,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1498,2,Drug diversion,Criminal activity,Legal issues,SocCi,N
1498,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1498,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1498,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
1499,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1499,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1500,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1500,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1501,1,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1501,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1501,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1501,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1502,1,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1503,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1503,2,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
1503,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1503,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1504,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1505,1,Alveolar proteinosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1505,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1505,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1505,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1505,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1505,6,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1505,7,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1506,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1506,2,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1506,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1506,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1506,5,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1506,6,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1506,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1506,8,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1507,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1508,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1508,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1508,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1508,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1508,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1509,1,Hypoventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1509,2,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1509,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1509,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1510,1,Therapeutic product effect prolonged,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1511,1,Therapeutic product effect prolonged,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1512,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1512,2,Gaze palsy,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1512,3,HIV-associated neurocognitive disorder,Retroviral infections,Viral infectious disorders,Infec,N
1512,4,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
1512,5,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1512,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1512,7,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1513,1,Drug diversion,Criminal activity,Legal issues,SocCi,N
1513,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1513,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1514,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1514,2,Postoperative respiratory distress,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1514,3,Pulmonary alveolar haemorrhage,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1515,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1515,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1515,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1515,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1516,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
1517,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1518,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1518,2,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1518,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1519,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1519,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1520,1,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1520,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1521,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1521,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1521,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1522,1,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1522,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1523,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1523,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1523,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1523,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1524,1,Application site laceration,Application site reactions,Administration site reactions,Genrl,N
1525,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1525,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1525,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1525,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1526,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1526,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1527,1,Hyporesponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1527,2,Snoring,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1528,1,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
1528,2,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1528,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1528,4,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1528,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1529,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1529,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1530,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1530,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1530,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1531,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1531,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1531,3,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1531,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1531,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1531,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1532,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1532,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1532,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1532,4,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1533,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1533,2,Maternal distress during labour,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
1533,3,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
1534,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1535,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1535,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1535,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1536,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1536,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1537,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1537,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1538,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1539,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1540,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1540,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1541,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1541,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1541,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1541,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1541,5,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1541,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1542,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1542,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1543,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1544,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1545,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1546,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1547,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1548,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1549,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1550,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1550,2,Headache,Headaches NEC,Headaches,Nerv,N
1550,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1550,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1551,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1551,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1551,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1551,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1551,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1551,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1552,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1553,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1553,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1554,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1555,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1555,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1556,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1556,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1557,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1557,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1558,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1559,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1559,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1560,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1561,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1562,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1562,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1562,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1562,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1563,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1564,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1564,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1565,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1565,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1565,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1565,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1566,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1566,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1566,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1566,4,Moaning,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1566,5,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1566,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1567,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1567,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1567,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1567,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1568,1,Catheter site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1568,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1568,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1568,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1568,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1568,6,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1568,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1568,8,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1568,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1569,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1569,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1569,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1570,1,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1571,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1571,2,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1571,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1572,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1573,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1573,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1573,3,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1573,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1574,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1575,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1575,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1575,3,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1575,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1576,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1576,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1577,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1577,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1577,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1578,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1578,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1579,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1579,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1579,3,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1579,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1580,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1581,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1581,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1581,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1581,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1582,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1582,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1582,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1583,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1583,2,Procedural hypotension,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1583,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1584,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1585,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1585,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1586,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1586,2,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1586,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1586,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1586,5,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1586,6,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1586,7,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1586,8,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1586,9,Dysphoria,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1586,10,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1586,11,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1586,12,Feelings of worthlessness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1586,13,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1586,14,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1586,15,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1586,16,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1586,17,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
1586,18,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1586,19,Patient dissatisfaction with treatment,Social issues NEC,Lifestyle issues,SocCi,N
1586,20,Product communication issue,Product transcribing errors and communication issues,Medication errors and other product use errors and issues,Inj&P,N
1586,21,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1586,22,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1586,23,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1586,24,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1586,25,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1586,26,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1586,27,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1587,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
1588,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1589,1,Amnestic disorder,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1589,2,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1589,3,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1589,4,Executive dysfunction,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
1589,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1589,6,Hypoxic-ischaemic encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1589,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1589,8,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1589,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1589,10,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1589,11,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1589,12,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1590,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1590,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1590,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1590,4,Euthyroid sick syndrome,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1590,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1590,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1590,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1590,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1590,9,Intensive care unit delirium,Deliria,Deliria (incl confusion),Psych,N
1590,10,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1590,11,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1590,12,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
1590,13,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1590,14,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1590,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1590,16,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
1590,17,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1591,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1591,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1591,3,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1591,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1591,5,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1591,6,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1591,7,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1591,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1591,9,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1591,10,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1591,11,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1591,12,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1591,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1591,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1591,15,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1591,16,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1592,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1592,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1592,3,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1593,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1593,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1594,1,Application site urticaria,Application site reactions,Administration site reactions,Genrl,N
1594,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1594,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1595,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1595,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1595,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1595,4,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1595,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1596,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1597,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1597,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1597,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1597,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1598,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1598,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1598,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1598,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1598,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1598,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1598,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1598,8,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1598,9,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1598,10,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1598,11,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1599,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1600,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
1600,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1601,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1602,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1602,2,Oxygen saturation immeasurable,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1602,3,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1603,1,Cardiac output decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1603,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1603,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1604,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1604,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1604,3,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1605,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1606,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1606,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1606,3,Nodal rhythm,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1606,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1606,5,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1607,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
1607,2,Myocardial depression,Myocardial disorders NEC,Myocardial disorders,Card,N
1608,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1609,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1609,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1610,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1610,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1610,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1610,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1610,5,Systolic hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1611,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1611,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1612,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
1612,2,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1612,3,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1612,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1612,5,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1612,6,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1612,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1613,1,Procedural hypotension,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1614,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1614,2,Skin test positive,Immunology skin tests NEC,Immunology and allergy investigations,Inv,N
1615,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1615,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1616,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1616,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1617,1,Apgar score abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1617,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1618,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1618,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1618,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1618,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1618,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1618,6,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
1619,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1619,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1620,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1620,2,Ventricular dyssynchrony,Myocardial disorders NEC,Myocardial disorders,Card,N
1621,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1621,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1621,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1622,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1622,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1622,3,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
1623,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1624,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1625,1,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1625,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1625,3,Long QT syndrome,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1625,4,Myocardial oedema,Myocardial disorders NEC,Myocardial disorders,Card,N
1625,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1625,6,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1625,7,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
1625,8,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1626,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1627,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,Y
1628,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1628,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1628,3,Hypermetropia,Refractive and accommodative disorders,Vision disorders,Eye,N
1628,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1629,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1630,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1631,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1632,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1632,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1632,3,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1632,4,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1633,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1633,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1633,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1633,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1633,5,Haematuria traumatic,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
1633,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1633,7,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1633,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1633,9,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1633,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1633,11,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1633,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1634,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1634,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1634,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1634,4,Euthyroid sick syndrome,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1634,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1634,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1634,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1634,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1634,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1634,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1634,11,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
1634,12,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1635,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1635,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1635,3,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1635,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1635,5,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1635,6,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1635,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1635,8,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1635,9,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1635,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1636,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1636,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1636,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1637,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1637,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1637,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1637,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1637,5,Haematuria traumatic,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
1637,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1637,7,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1637,8,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1637,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1637,10,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1637,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1637,12,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1637,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1638,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1638,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1638,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1639,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1639,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
1640,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1640,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1640,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1640,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1640,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1640,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1640,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1640,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1641,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1641,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1641,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1642,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1642,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1643,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1644,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1644,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1644,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1645,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1645,2,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1645,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1645,4,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1645,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1645,6,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1646,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1646,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1646,3,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1646,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1646,5,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1646,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1646,7,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1646,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1646,9,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1646,10,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1646,11,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1646,12,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1646,13,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1646,14,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1646,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1646,16,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
1646,17,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1647,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1648,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1648,2,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1648,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1648,4,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1648,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1648,6,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1648,7,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1649,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1649,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1649,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1650,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1650,2,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
1650,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1650,4,Haematuria traumatic,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
1650,5,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1650,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1650,7,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1650,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1650,9,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1650,10,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1650,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1650,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1650,13,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1650,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1651,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1651,2,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1651,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1651,4,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1652,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1652,2,Euthyroid sick syndrome,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1652,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1652,4,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1652,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1652,6,Intensive care unit delirium,Deliria,Deliria (incl confusion),Psych,N
1652,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1652,8,Neuromyopathy,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
1652,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1653,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1653,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1653,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1653,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1653,5,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1653,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1653,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1653,8,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1654,1,Chest expansion decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1654,2,Flail chest,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
1654,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1654,4,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1655,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1655,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1656,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1656,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1656,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1656,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1656,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1656,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1656,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1656,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1657,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1657,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1658,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1659,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1660,1,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1660,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1660,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1661,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1661,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1662,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1663,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1664,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1665,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1666,1,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1666,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1667,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1667,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1667,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1667,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1668,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1668,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1668,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1668,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1668,5,Hepatic ischaemia,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1668,6,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1668,7,Hepatorenal syndrome,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1668,8,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1668,9,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1668,10,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1668,11,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1668,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1668,13,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1669,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1670,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1671,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1671,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1672,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1672,2,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1672,3,Impulsive behaviour,Impulse control disorders,Impulse control disorders NEC,Psych,N
1672,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1672,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1672,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1672,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1672,8,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1673,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1673,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1673,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1673,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1673,5,Post lumbar puncture syndrome,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1673,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1674,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1674,2,Euthyroid sick syndrome,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1674,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1674,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1674,5,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1674,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1674,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1674,8,Neuromyopathy,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
1674,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1674,10,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1674,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1674,12,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1675,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1675,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1675,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1675,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1675,5,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1675,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1675,7,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1675,8,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1675,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1675,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1675,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1675,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1675,13,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1676,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1676,2,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1676,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1676,4,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1676,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1676,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1677,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1678,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1679,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1679,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1679,3,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1679,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1679,5,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1679,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1680,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1680,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1680,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1680,4,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1680,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1681,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1681,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1681,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1681,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1682,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1682,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1682,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1682,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1682,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1683,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1683,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1683,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1683,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1683,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1683,6,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1684,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1684,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1685,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1685,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1686,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1687,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1687,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1688,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1688,2,Carcinoid crisis,Ectopic endocrine disorders,Neoplastic and ectopic endocrinopathies,Endo,N
1688,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1688,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1689,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1689,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1689,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1689,4,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1689,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1690,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1690,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1690,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1691,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1691,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1692,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1692,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1692,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1692,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1692,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1692,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1692,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1692,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1692,9,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1692,10,Sweat discolouration,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1692,11,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1693,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1693,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1694,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1694,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1695,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1695,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1695,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1695,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1695,5,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1695,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1695,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1696,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1696,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1696,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1696,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1696,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1696,6,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1696,7,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1696,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1696,9,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1696,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1697,1,Carcinoid crisis,Ectopic endocrine disorders,Neoplastic and ectopic endocrinopathies,Endo,N
1697,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1697,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1698,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1698,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1699,1,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
1700,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1700,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1700,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1701,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1701,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
1701,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1701,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1701,5,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1701,6,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1701,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1702,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1702,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1702,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1702,4,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1703,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1703,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1703,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1704,1,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1704,2,Unwanted awareness during anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1705,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1706,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1706,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1706,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1706,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1706,5,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1706,6,Post lumbar puncture syndrome,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1706,7,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1707,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1707,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1707,3,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1708,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1708,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1708,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1709,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1710,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1710,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1710,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1710,4,Post lumbar puncture syndrome,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1710,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1710,6,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1710,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1710,8,Subdural hygroma,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1711,1,Carcinoid crisis,Ectopic endocrine disorders,Neoplastic and ectopic endocrinopathies,Endo,N
1712,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1712,2,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1712,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1713,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1713,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1713,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1714,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1715,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1715,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1715,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1715,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1716,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1717,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1717,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1717,3,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1718,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
1719,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1720,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1721,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1721,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1721,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1721,4,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1722,1,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1722,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1722,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1723,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1723,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1724,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1724,2,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1724,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1724,4,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1724,5,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1724,6,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1724,7,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1724,8,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1724,9,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1724,10,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1724,11,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1724,12,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1724,13,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1724,14,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1724,15,Intentional device misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1724,16,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1724,17,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1724,18,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1724,19,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1724,20,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1724,21,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1725,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1726,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1727,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1727,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1727,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1728,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1728,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1728,3,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1728,4,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1728,5,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1728,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1729,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1729,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1730,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1730,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1730,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1730,4,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1730,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1730,6,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1730,7,Supraventricular extrasystoles,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1730,8,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1731,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1731,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1731,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1731,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1731,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1732,1,Medical device repositioning,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1733,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1733,2,Grunting,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1733,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1733,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1733,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1734,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1734,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1734,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1734,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1734,5,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1735,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1735,2,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1736,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1736,2,Hereditary angioedema with C1 esterase inhibitor deficiency,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1736,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1736,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1737,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1738,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1739,1,Seizure prophylaxis,Nervous system therapeutic procedures NEC,"Nervous system, skull and spine therapeutic procedures",Surg,N
1740,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1740,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1740,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1740,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1740,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1741,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1742,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1742,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1742,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1742,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1742,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1742,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1743,1,Allodynia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1743,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1743,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1743,4,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1743,5,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1743,6,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1743,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1743,8,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1743,9,Soliloquy,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1743,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1744,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1744,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1744,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1744,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1745,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1746,1,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1747,1,Executive dysfunction,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
1748,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1748,2,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1748,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1748,4,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1748,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1748,6,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1748,7,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1749,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1749,2,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
1749,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1749,4,Weight decrease neonatal,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1750,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1750,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1750,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1751,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1751,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1751,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1752,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1752,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1752,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1753,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1753,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1753,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1754,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1754,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1755,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1755,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1756,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1756,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1757,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1757,2,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1757,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1758,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1758,2,Headache,Headaches NEC,Headaches,Nerv,N
1758,3,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1759,1,Abdominal compartment syndrome,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1759,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1759,3,Acute lung injury,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1759,4,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1759,5,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1759,6,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1759,7,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1759,8,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1759,9,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
1759,10,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
1759,11,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1759,12,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1759,13,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1759,14,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1759,15,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1759,16,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1759,17,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1759,18,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1759,19,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1759,20,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1759,21,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1759,22,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1759,23,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1759,24,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1759,25,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1759,26,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1759,27,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1759,28,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1759,29,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1759,30,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1759,31,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1759,32,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1760,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1760,2,Headache,Headaches NEC,Headaches,Nerv,N
1760,3,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1761,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1761,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1762,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
1762,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1763,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1763,2,Body dysmorphic disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
1763,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1763,4,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1763,5,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1763,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1763,7,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1763,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1763,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1763,10,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1764,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1764,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1764,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1764,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1764,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1764,6,Spinal anaesthesia,Anaesthesia and allied procedures,Therapeutic procedures and supportive care NEC,Surg,N
1765,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1765,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1765,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1765,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1766,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1766,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1766,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1767,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1768,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1768,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1768,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1768,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1769,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1770,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1770,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1770,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1771,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1771,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1772,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1772,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1772,3,Product dispensing issue,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1773,1,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1773,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1774,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1774,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1774,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1774,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1775,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1775,2,Body dysmorphic disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
1775,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1775,4,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1775,5,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1775,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1775,7,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1775,8,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1775,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1775,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1775,11,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1776,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1776,2,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1777,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1778,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1778,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1778,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1779,1,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1779,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1780,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1781,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1781,2,Body dysmorphic disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
1781,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1781,4,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1781,5,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1781,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1781,7,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1781,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1781,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1781,10,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1782,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1782,2,Dyspnoea at rest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1783,1,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1784,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
1784,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1785,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1786,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1786,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1786,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1787,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1788,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1788,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1789,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
1789,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1790,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1790,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1791,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1791,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1791,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1791,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1792,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1793,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1793,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1793,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1793,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1794,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1795,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1796,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
1796,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1796,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1796,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1797,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1797,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1798,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1798,2,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1799,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1800,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1800,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1800,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1801,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,Y
1802,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1803,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1803,2,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1803,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1804,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1804,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1805,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1805,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1806,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1806,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1807,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1807,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1807,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1807,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1807,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1808,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1808,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1808,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1809,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1809,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1810,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1810,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1810,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1810,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1810,5,Tic,Tic disorders,Changes in physical activity,Psych,N
1811,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1811,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1811,3,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1811,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1812,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1812,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1813,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1813,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1814,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1814,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1815,1,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1815,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1816,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1817,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1817,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1817,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1817,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1818,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1819,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1819,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1819,3,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1820,1,Long QT syndrome,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1820,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1821,1,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1821,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1821,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1821,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1821,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1821,6,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1822,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1822,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1823,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1824,1,Central nervous system stimulation,Nervous system therapeutic procedures NEC,"Nervous system, skull and spine therapeutic procedures",Surg,N
1825,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1826,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1827,1,Central nervous system stimulation,Nervous system therapeutic procedures NEC,"Nervous system, skull and spine therapeutic procedures",Surg,N
1828,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1828,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1828,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1828,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1828,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1828,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1828,7,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1829,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1830,1,Central nervous system stimulation,Nervous system therapeutic procedures NEC,"Nervous system, skull and spine therapeutic procedures",Surg,N
1831,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1831,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1831,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1831,4,Headache,Headaches NEC,Headaches,Nerv,N
1831,5,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1831,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1831,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1831,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1832,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1833,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1833,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1834,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1834,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1834,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1834,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1834,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1835,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1835,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1836,1,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1837,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1838,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1838,2,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1839,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1839,2,Device placement issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1839,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1839,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1840,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1840,2,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1840,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1840,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1841,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1841,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1841,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1841,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1842,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1842,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1843,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1844,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1844,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1844,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1845,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1846,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1846,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1846,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1846,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1846,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1846,6,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1846,7,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1846,8,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1846,9,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1846,10,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1846,11,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1846,12,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1846,13,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1846,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1847,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1847,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1848,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1848,2,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
1849,1,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1849,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1849,3,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1849,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1849,5,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1850,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1851,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1851,2,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
1852,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1852,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1853,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1854,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1855,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1856,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1856,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1857,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1858,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1858,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1858,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1858,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1858,5,Hepatic ischaemia,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1858,6,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1858,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1859,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1859,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1860,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1860,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1860,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1861,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1861,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1861,3,Menopause,Age related issues,Age related factors,SocCi,N
1861,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1862,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1863,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1863,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1864,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1865,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1865,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1865,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1865,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1865,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1866,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1866,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1867,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1867,2,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1867,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1868,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1868,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1868,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1868,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1869,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1870,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1871,1,Erythema ab igne,Erythemas,Epidermal and dermal conditions,Skin,N
1871,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1872,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1873,1,Blood triglycerides abnormal,Triglyceride analyses,Lipid analyses,Inv,N
1873,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,Y
1873,3,Propofol infusion syndrome,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1874,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1874,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1874,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1874,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1875,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1875,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1875,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1875,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1876,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1877,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1877,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1878,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1878,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
1878,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1878,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1878,5,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1879,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1879,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1879,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1880,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1880,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1880,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1880,4,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1881,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1882,1,Drug use disorder,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1882,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1883,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1883,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1884,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1885,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1885,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1885,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1886,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1886,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1886,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1886,4,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1886,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1887,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1887,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1887,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1887,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1887,5,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1887,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1887,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1888,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1889,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1889,2,Symmetrical drug-related intertriginous and flexural exanthema,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1890,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1891,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1891,2,Headache,Headaches NEC,Headaches,Nerv,N
1892,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1892,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1893,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1893,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1894,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1894,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1894,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1894,4,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1894,5,Preterm premature rupture of membranes,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
1895,1,Apgar score low,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1895,2,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1895,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1895,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1896,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1896,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1897,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1897,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1897,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1898,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1898,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1898,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1898,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1898,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1898,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1898,7,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1898,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1898,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1898,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1899,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1900,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1901,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1901,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1901,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1902,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1902,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1902,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1902,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1902,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1903,1,Homicide,Criminal activity,Legal issues,SocCi,Y
1903,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1904,1,Homicide,Criminal activity,Legal issues,SocCi,Y
1905,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1905,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1906,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1906,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1906,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1906,4,New onset refractory status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1906,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1907,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1907,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1908,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1908,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1908,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1908,4,Preterm premature rupture of membranes,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
1908,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1909,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1909,2,Foetal dystocia,Foetal position and presentation abnormalities,Foetal complications,Preg,N
1909,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1909,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1910,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1910,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1910,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1911,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1911,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1912,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1912,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1912,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1912,4,Preterm premature rupture of membranes,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
1913,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1914,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1915,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1915,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1916,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1916,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1916,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1916,4,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1916,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1916,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1917,1,Alcoholic liver disease,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1917,2,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,Y
1917,3,Homicide,Criminal activity,Legal issues,SocCi,N
1917,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1918,1,Homicide,Criminal activity,Legal issues,SocCi,N
1918,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1918,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1919,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1920,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1920,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1920,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1921,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1922,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1922,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1922,3,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1922,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1923,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1924,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1924,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1924,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1925,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1926,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1926,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1926,3,Suspected product contamination,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1926,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1926,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1927,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1927,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1928,1,Neurogenic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1929,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1930,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1931,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1932,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1932,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1932,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1933,1,Headache,Headaches NEC,Headaches,Nerv,N
1934,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1935,1,Arachnoiditis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
1935,2,Cauda equina syndrome,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
1935,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1935,4,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1935,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1935,6,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1935,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1935,8,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1935,9,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1935,10,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1935,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1935,12,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1935,13,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1936,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1937,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1938,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1938,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1938,3,Tonic clonic movements,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1939,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1939,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1939,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1939,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1939,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1939,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1939,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1940,1,Dissociative amnesia,Dissociative states,Dissociative disorders,Psych,N
1940,2,Retrograde amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1941,1,Retrograde amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1942,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1943,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1943,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1943,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1943,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1943,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1944,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1945,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1945,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1945,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1945,4,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1946,1,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1946,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1947,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1947,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1948,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1949,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1949,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1949,3,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1949,4,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1949,5,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1949,6,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1949,7,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1949,8,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1949,9,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1949,10,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1949,11,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1949,12,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1949,13,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
1949,14,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1949,15,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1949,16,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1949,17,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1949,18,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1950,1,Homicide,Criminal activity,Legal issues,SocCi,N
1950,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1951,1,Homicide,Criminal activity,Legal issues,SocCi,N
1951,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1952,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1952,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1952,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1952,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1952,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1952,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1952,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1952,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
1952,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1952,10,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1952,11,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1952,12,Urine output,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1952,13,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1952,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1953,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1954,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1955,1,Coagulation time abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1955,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1955,3,Dermal absorption increased,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1955,4,Drowning,Death and sudden death,Fatal outcomes,Genrl,Y
1955,5,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1955,6,Drug tolerance increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1955,7,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1955,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1955,9,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1955,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1955,11,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1955,12,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1955,13,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1956,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1956,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1956,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1957,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1958,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1959,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1960,1,Dysphoria,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1961,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1962,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1963,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1964,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1965,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1966,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1966,2,Foetal heart rate abnormal,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
1966,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1967,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1967,2,Foetal heart rate abnormal,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
1967,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1968,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1968,2,Cardiac dysfunction,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1968,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1968,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1968,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1968,6,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1968,7,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1969,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1970,1,Multiple drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
